{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:59:16Z","timestamp":1783137556570,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ymgme.2006.09.007","type":"journal-article","created":{"date-parts":[[2006,11,4]],"date-time":"2006-11-04T12:14:20Z","timestamp":1162642460000},"page":"122-125","source":"Crossref","is-referenced-by-count":13,"title":["Therapy for Gaucher disease: Don\u2019t stop thinking about tomorrow"],"prefix":"10.1016","volume":"90","author":[{"given":"Ellen","family":"Sidransky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"LaMarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward I.","family":"Ginns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2006.09.007_bib1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2006.09.007_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2006.09.007_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the gaucher registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2006.09.007_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3476(96)70203-2","article-title":"Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase","volume":"129","author":"Kaplan","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2006.09.007_bib5","first-page":"158","article-title":"Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and\/or enzyme replacement therapy","volume":"2","author":"Kauli","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.ymgme.2006.09.007_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/bcmd.1995.0012","article-title":"The clinical course of treated and untreated Gaucher disease. A study of 45 patients","volume":"21","author":"Beutler","year":"1995","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2006.09.007_bib7","doi-asserted-by":"crossref","unstructured":"NIH Technology Assessment Panel on Gaucher Disease, Gaucher disease \u2013 Current issues in diagnosis and treatment, NIH Technology Assessment Panel on Gaucher Disease, JAMA 275 (1996) 548\u2013553.","DOI":"10.1001\/jama.275.7.548"},{"key":"10.1016\/j.ymgme.2006.09.007_bib8","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2006.09.007_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher\u2019s disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2006.09.007_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ymgme.2006.01.010","article-title":"Lysosomal storage diseases: natural history and ethical and economic aspects","volume":"88","author":"Beutler","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2006.09.007_bib11","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2006.09.007_bib12","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2006.09.007_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1098\/rstb.2003.1272","article-title":"Gaucher disease and the clinical experience with substrate reduction therapy","volume":"358","author":"Zimran","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ymgme.2006.09.007_bib14","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1182\/blood.V83.9.2737.2737","article-title":"Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone-marrow transplantation","volume":"83","author":"Krall","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2006.09.007_bib15","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V86.3.1218.1218","article-title":"Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients\u2014successful engraftment and long-term expression of the transgene","volume":"86","author":"Schiffmann","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2006.09.007_bib16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1089\/hum.1998.9.16-2375","article-title":"Long-term expression, systemic delivery, and macrophage uptake of recombinant human glucocerebrosidase in mice transplanted with genetically modified primary myoblasts","volume":"9","author":"Liu","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2006.09.007_bib17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgm.732","article-title":"Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector","volume":"7","author":"Kim","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgme.2006.09.007_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jgm.901","article-title":"AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease","volume":"8","author":"McEachern","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgme.2006.09.007_bib19","first-page":"2629","article-title":"Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation","volume":"9","author":"Dunbar","year":"1998","journal-title":"Hum. Gene The."},{"key":"10.1016\/j.ymgme.2006.09.007_bib20","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1089\/hum.1997.8.17-2143","article-title":"Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher\u2019s disease","volume":"8","author":"Schuening","year":"1997","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/j.ymgme.2006.09.007_bib21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1517\/14712598.1.5.857","article-title":"Gene therapy for lysosomal storage disorders","volume":"1","author":"Barranger","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymgme.2006.09.007_bib22","unstructured":"E.I. Ginns, D.M. Faryna, M. Galdzicka, C. Chrzanowski, and G.R. Ostroff, Development of a novel orally administered macrophage mediated gene therapy for Gaucher disease, Presented at the annual meeting of The American Society of Human Genetics, October, 2005, Salt Lake City, Utah, Plenary session 10 (2005) A2."},{"key":"10.1016\/j.ymgme.2006.09.007_bib23","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2006.09.007_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","article-title":"A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity","volume":"24","author":"Fan","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymgme.2006.09.007_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cbic.200390045","article-title":"Chemical chaperones\u2014a new concept in drug research","volume":"4","author":"Kolter","year":"2003","journal-title":"Chembiochem."},{"key":"10.1016\/j.ymgme.2006.09.007_bib26","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ymgme.2006.09.007_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymgme.2006.09.007_bib28","series-title":"Gaucher Disease","first-page":"125","article-title":"The development of enzyme replacement therapy for lysosomal diseases: Gaucher disease and beyond","author":"Schuchman","year":"2006"},{"key":"10.1016\/j.ymgme.2006.09.007_bib29","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2002-09-2853","article-title":"ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface","volume":"101","author":"Murciano","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2006.09.007_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1570161043385736","article-title":"Endothelial endocytic pathways: gates for vascular drug delivery","volume":"2","author":"Muro","year":"2004","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ymgme.2006.09.007_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/bc980044l","article-title":"Bispecific antibodies as novel bioconjugates","volume":"9","author":"Cao","year":"1998","journal-title":"Bioconjug. Chem."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719206003027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719206003027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T10:49:12Z","timestamp":1628074152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719206003027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1096719206003027"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2006.09.007","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}